To assess the function of DCD in breast cancer cells with high endogenous expression, we generated derivatives of the MDA-MB-361 human breast cancer cell line expressing three different shRNAs against DCD (IBC-I, IBC-II, and IBC-III) using pLKO plasmid-derived lentiviruses. The gene discussed is DCD; the disease is breast cancer.